Compare TEO & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEO | IRTC |
|---|---|---|
| Founded | 1979 | 2006 |
| Country | Argentina | United States |
| Employees | 27818 | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.8B |
| IPO Year | N/A | 2016 |
| Metric | TEO | IRTC |
|---|---|---|
| Price | $11.67 | $121.02 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $9.80 | ★ $204.46 |
| AVG Volume (30 Days) | 259.4K | ★ 462.7K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.71% | N/A |
| EPS Growth | N/A | ★ 61.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $747,138,000.00 |
| Revenue This Year | $4.91 | $19.60 |
| Revenue Next Year | $1.58 | $15.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.24 |
| 52 Week Low | $6.43 | $95.74 |
| 52 Week High | $13.81 | $210.01 |
| Indicator | TEO | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 52.32 | 46.72 |
| Support Level | $10.87 | $119.48 |
| Resistance Level | $12.11 | $124.40 |
| Average True Range (ATR) | 0.62 | 4.55 |
| MACD | 0.02 | 1.47 |
| Stochastic Oscillator | 64.44 | 67.39 |
Telecom Argentina SA offers its customers quadruple play services, combining mobile telephony services, cable television services, Internet services and fixed telephony services. It also provides other telephone-related services such as international long-distance and wholesale services, data transmission and IT solutions outsourcing and install, operate and develop cable television and data transmission services. The company operates in segments: ICT Services provided in Argentina: Personal Network; ICT Services provided in Argentina - TMA Network; and Other segments..
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.